Cargando…
Major histocompatibility complex Class II-based therapy for stroke
This review discusses the potential of major histocompatibility complex (MHC) Class II constructs as stroke therapeutics. We focus on the delivery of MHC Class II construct, DRmQ, as a safe and effective treatment for ischemic stroke. DRmQ was observed to attenuate behavioral deficits and decrease m...
Autores principales: | Gonzales-Portillo, Bella M., Lee, Jea-Young, Vandenbark, Arthur A., Offner, Halina, Borlongan, Cesario V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057100/ https://www.ncbi.nlm.nih.gov/pubmed/34084976 http://dx.doi.org/10.4103/bc.bc_16_21 |
Ejemplares similares
-
Spleen participation in partial MHC class II construct neuroprotection in stroke
por: Brown, John, et al.
Publicado: (2020) -
Hyperbaric oxygen therapy: A new look on treating stroke and traumatic brain injury
por: Gonzales-Portillo, Bella, et al.
Publicado: (2019) -
The Marine Mammal Class II Major Histocompatibility Complex Organization
por: de Sá, André Luiz Alves, et al.
Publicado: (2019) -
Sex-dependent treatment of chronic EAE with partial MHC class II constructs
por: Benedek, Gil, et al.
Publicado: (2017) -
Characterization of the Major Histocompatibility Complex Class II Genes in Miiuy Croaker
por: Xu, Tianjun, et al.
Publicado: (2011)